Keyphrases
Vascular Adhesion protein-1 (VAP-1)
100%
Hepatic Steatosis
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
46%
Steatosis
20%
Hepatocytes
13%
Lipids
13%
Recombinant
13%
Lipid Accumulation
13%
Triglycerides
13%
Semicarbazide-sensitive Amine Oxidase
13%
Human Liver Tissue
13%
Methylamine
13%
Antioxidant
6%
Inflammatory Response
6%
Developed Countries
6%
Disease Stage
6%
Murine Model
6%
PCR Analysis
6%
Insulin Resistance
6%
Enzyme Activity
6%
Obesity
6%
Inflammatory Gene Expression
6%
High Prevalence
6%
Clinical Trials
6%
Insulin Sensitizers
6%
Therapeutic Strategies
6%
Receptor Subunits
6%
Dyslipidemia
6%
Screening Cost
6%
Multifunctional Protein
6%
Immunohistochemical Analysis
6%
Standard of Care
6%
Lipid Uptake
6%
Cirrhosis
6%
Insulin Receptor
6%
High-fat Diet
6%
Oxidase Enzymes
6%
Lifestyle Intervention
6%
Metabolic Disturbances
6%
Patient-specific Therapy
6%
Metabolic Inflammation
6%
Oxidase Activity
6%
Caveolin-1 (Cav-1)
6%
Nonalcoholic Steatohepatitis
6%
Disease Spectrum
6%
Hepatic Lipid Accumulation
6%
Hepatic Lipid
6%
Oil Red O
6%
Histological Stage
6%
Transporter Molecules
6%
Fibrosis Stage
6%
Lipid Transporter
6%
Hydrogen Peroxide Accumulation
6%
AOC3
6%
Amine Oxidase
6%
FABP3
6%
PPARGC1
6%
Gene Expression Array
6%
FABP2
6%
VLDLR
6%
Fatty Liver Progression
6%
Precision-cut Liver Slices
6%
Modifying Gene
6%
Limited Treatment Options
6%
Medicine and Dentistry
In Vitro
100%
Fatty Liver
100%
Vascular Adhesion Protein-1
100%
Nonalcoholic Fatty Liver
53%
Lipid Storage
20%
Steatosis
20%
Gene Expression
13%
Triacylglycerol
13%
Hepatocyte
13%
Liver Tissue
13%
Methylamine
13%
Amine Oxidase (Copper-Containing)
13%
Hydrogen Peroxide
6%
Antioxidant
6%
Health Care Cost
6%
Enzyme Activity
6%
High Fat Food
6%
Serositis
6%
Population
6%
Clinical Trial
6%
Prevalence
6%
Insulin Resistance
6%
Fibrosis
6%
Lifestyle Intervention
6%
Dyslipidemia
6%
Peroxisome Proliferator Activated Receptor
6%
Insulin Receptor
6%
Real-Time Polymerase Chain Reaction
6%
Receptor Subunit
6%
Water-Electrolyte Imbalance
6%
Insulin Sensitizing Agent
6%
Caveolin 1
6%
Liver Cirrhosis
6%
Expression Array
6%
Liver Slice
6%
2 Bromoethylamine
6%
AOC3
6%
Amine Oxidase (Flavin Containing)
6%
Diseases
6%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Vascular Adhesion Protein 1
100%
Nonalcoholic Fatty Liver
53%
Steatosis
20%
Inflammation
13%
Triacylglycerol
13%
Methylamine
13%
Amine Oxidase (Copper Containing)
13%
Hydrogen Peroxide
6%
Amine Oxidase (Flavin Containing)
6%
Antioxidant
6%
Insulin Resistance
6%
Prevalence
6%
Fibrosis
6%
Clinical Trial
6%
Dyslipidemia
6%
Peroxisome Proliferator Activated Receptor
6%
Liver Cirrhosis
6%
Receptor Subunit
6%
Insulin Receptor
6%
Insulin Sensitizing Agent
6%
Caveolin 1
6%
2 Bromoethylamine
6%
Expression Array
6%
Metabolic Disorder
6%
Diseases
6%
Biochemistry, Genetics and Molecular Biology
Synapsin I
100%
Adhesion Protein
100%
Lipid
20%
Lipid Storage
20%
Hepatocyte
13%
Gene Expression
13%
Triglyceride
13%
Lipid Liver Level
13%
Amine Oxidase (Copper-Containing)
13%
Enzyme
6%
Hydrogen Peroxide
6%
Sensitization
6%
Enzyme Activity
6%
Clinical Trial
6%
Insulin Resistance
6%
Real-Time Polymerase Chain Reaction
6%
Population
6%
Prevalence
6%
Insulin Receptor
6%
Peroxisome Proliferator-Activated Receptor
6%
Metabolic Disorder
6%
Dyslipidemia
6%
Caveolin 1
6%
Monoamine Oxidase
6%
FABP2
6%
AOC3
6%
Amine Oxidase
6%